Monsenso

Monsenso is a digital health technology company building software for decentralised clinical trials, remote patient monitoring and treatment support, with a focus on mental health and psychiatry. Its technical work spans patient-reported outcomes (ePRO), e-consent, wearables integration and behavioural data collection, applied to the delivery and measurement of care outside traditional clinical settings.

The Monsenso digital health solution connects individuals, carers and clinicians on a single platform. It captures patient data through e-consent, ePRO and a suite of wearables to build a holistic view of the patient journey, gathering outcome, adherence and behavioural data to support personalised treatment, remote care and early intervention. The product is a CE-marked Class 1 medical device.

The company's work sits at the intersection of mental health, psychiatry, healthcare, social care, pharmaceuticals and clinical research, serving both care delivery and clinical research use cases. Its stated mission is to contribute to improved health for more people at lower costs, using digital treatment support and patient-reported outcomes data to help individuals, carers and clinicians manage the burden of mental illness.

Monsenso can be reached at https://monsenso.com/.